Structure of PI3K gamma in complex with GDC0941
The structure was published by Folkes, A.J., Ahmadi, K., Alderton, W.K., et al., Zhyvoloup, A., Zvelebil, M.J., and Shuttleworth, S.J., in 2008 in a paper entitled "The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer" (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 2.8 Å and deposited in 2008.
The experimental data on which the structure is based was also deposited.
The PDB entry contains the structure of Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform. This molecule has the UniProt identifier P48736 (PK3CG_HUMAN). The sample contained 960 residues which is < 90% of the natural sequence. Out of 960 residues 840 were observed and are deposited in the PDB.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule is most likely monomeric.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: